Revance Therapeutics (RVNC) Insider Trading & Ownership $3.65 0.00 (0.00%) As of 02/6/2025 Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Revance Therapeutics (NASDAQ:RVNC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$143,642.48 Get RVNC Insider Trade Alerts Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RVNC Insider Buying and Selling by Quarter Revance Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/16/2024Erica JordanInsiderSell2,392$3.80$9,089.60 3/18/2024Dustin S SjutsPresidentSell9,211$5.04$46,423.44 3/18/2024Dwight MoxieInsiderSell8,125$5.04$40,950.00 3/18/2024Tobin SchilkeCFOSell9,361$5.04$47,179.44 (Data available from 1/1/2013 forward) RVNC Insider Trading Activity - Frequently Asked Questions Who is on Revance Therapeutics's Insider Roster? The list of insiders at Revance Therapeutics includes Carey Oconnor Kolaja, Dustin S Sjuts, Dwight Moxie, Erica Jordan, Mark J Foley, and Tobin Schilke. Learn more on insiders at RVNC. What percentage of Revance Therapeutics stock is owned by insiders? 5.10% of Revance Therapeutics stock is owned by insiders. Learn more on RVNC's insider holdings. Which Revance Therapeutics insiders have been selling company stock? The following insiders have sold RVNC shares in the last 24 months: Carey Oconnor Kolaja ($70,600.00), Dustin S Sjuts ($1,606,029.41), Dwight Moxie ($1,789,465.12), Erica Jordan ($9,089.60), Mark J Foley ($6,866,970.12), and Tobin Schilke ($1,068,911.43). How much insider selling is happening at Revance Therapeutics? Insiders have sold a total of 400,058 Revance Therapeutics shares in the last 24 months for a total of $11,411,065.68 sold. Revance Therapeutics Key ExecutivesMr. Mark J. Foley (Age 59)CEO & Director Compensation: $1.26MMr. Tobin C. Schilke (Age 49)CFO & Principal Accounting Officer Compensation: $731.58kMr. Dwight O. Moxie (Age 48)Chief Legal Officer & General Counsel Compensation: $713.82kJessica SerraHead of Investor Relations & ESGMs. Jeanie D. HerbertSenior Director of Investor Relations & Corporate CommunicationsMs. Taryn ConwayVice President of MarketingMs. Amie KrauseChief People OfficerDr. Conor GallagherHead of Medical Affairs & AestheticsDr. David A. Hollander M.B.A. (Age 49)M.D., Chief Medical Officer of Global Therapeutics Franchise Lead Ms. Erica Jordan (Age 47)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies IMCR Insider Trading DYN Insider Trading KNSA Insider Trading GPCR Insider Trading NRIX Insider Trading ARQT Insider Trading ARDX Insider Trading ARVN Insider Trading SNDX Insider Trading VIR Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (NASDAQ:RVNC) was last updated on 2/13/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revance Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revance Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVNC Stock Alerts